Monica Sam
Nurse Practitioner · Wilmington, DENPI 1184115354
Payments from drug & device makers
What this record shows
21 manufacturers reported payments, led by Incyte Corporation at 58.3% of the total. Reporting peaked in 2021 at $3,894 and has fallen 61.4% since, to $1,504 in 2025. Among nurse practitioner clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 47 payments — averaging $158.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$4K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$486
- Otsuka America Pharmaceutical, Inc.$302
- Axsome Therapeutics, Inc.$287
- Lilly USA, LLC$255
- Neurocrine Biosciences, Inc.$253
- plus $2K from 15 others
What the payments were for
- Speaking & faculty fees$4,35158%
- Food & beverage$3,11742%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 3 | $4,351 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $486 |
| Otsuka America Pharmaceutical, Inc. | 5 | $302 |
| Axsome Therapeutics, Inc. | 3 | $287 |
| Lilly USA, LLC | 6 | $255 |
| Neurocrine Biosciences, Inc. | 2 | $253 |
| Vanda Pharmaceuticals Inc. | 2 | $237 |
| Gilead | 2 | $202 |
| AbbVie | 3 | $172 |
| Johnson & Johnson | 2 | $124 |
| Verona Pharma, Inc. | 1 | $124 |
| United Therapeutics Corporation | 2 | $120 |
| Abbott | 1 | $97 |
| Braeburn Inc. | 1 | $92 |
| GSK | 1 | $69 |
| E.r. Squibb & Sons, L.L.C. | 1 | $66 |
| Alkermes, Inc. | 1 | $66 |
| Novo Nordisk | 1 | $59 |
| AstraZeneca | 3 | $57 |
| Merck | 2 | $36 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$486
- INGREZZA$253
- Fanapt$237
- Ohtuvayre$124
- ABILIFY MYCITE$122
- Auvelity$119
- INVEGA SUSTENNA$101
- MOUNJARO$100
How this compares
$7,468 in reported general payments places this provider in the 95th percentile of 487 nurse practitioner providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Wilmington
- Colleen DitroWilmington$16K
- Jennifer HubbardWilmington$12K
- Brenda NardozziWilmington$7K
- Ellen NeffWilmington$5K
- Tina CubetaWilmington$5K
- Auxilia AkalaWilmington$3K
- Melissa LehrWilmington$3K
- Cathy RamageWilmington$2K
- Meghan McCarterSeaford$170K
- Chandni PatelMiddletown$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.